Danaher Corporation
DAP.DE · Deutsche Börse · EUR
209,90EUR
+2,30 (+1,11 %)Stand 10. Nov., 12:17
Kennzahlen
- Eröffnung
- 209,00
- Vortag
- 207,60
- Tagesspanne
- 209,00 – 209,90
- 52 Wochen
- 138,20 – 214,50
- Volumen
- 14
- Ø Volumen
- 693
- Börsenwert
- 147,67 Mrd. €
- KGV
- –
- Gewinn je Aktie (TTM)
- 6,14
- Dividendenrendite
- –
- Beta
- 0,8
- Nächste Zahlen
- –
Finanzen
| USD | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 24,57 Mrd. | 23,88 Mrd. | 23,89 Mrd. | 31,47 Mrd. | 29,45 Mrd. |
| Herstellungskosten | 10,05 Mrd. | 9,67 Mrd. | 9,76 Mrd. | 12,52 Mrd. | 11,5 Mrd. |
| Bruttogewinn | 14,52 Mrd. | 14,21 Mrd. | 14,13 Mrd. | 18,95 Mrd. | 17,95 Mrd. |
| Forschung und Entwicklung | 1,6 Mrd. | 1,58 Mrd. | 1,5 Mrd. | 1,75 Mrd. | 1,74 Mrd. |
| Vertrieb und Verwaltung | 8,24 Mrd. | 7,76 Mrd. | 7,25 Mrd. | 8,52 Mrd. | 8,2 Mrd. |
| Operatives Ergebnis | 4,69 Mrd. | 4,86 Mrd. | 5,2 Mrd. | 8,69 Mrd. | 7,47 Mrd. |
| EBITDA | 6,95 Mrd. | 7,28 Mrd. | 7,5 Mrd. | 9,48 Mrd. | 8,8 Mrd. |
| Nettogewinn | 3,61 Mrd. | 3,9 Mrd. | 4,76 Mrd. | 7,21 Mrd. | 6,43 Mrd. |
| Gewinn je Aktie (verwässert) | 5,05 | 5,29 | 5,65 | 9,66 | 8,61 |
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
Danaher Corporation is a global enterprise that develops, produces, and sells a diverse range of specialized products and services tailored for the professional, healthcare, industrial, and commercial sectors. Its operations are organized into three primary divisions: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences division delivers cutting-edge tools and solutions such as mass spectrometers, flow cytometry systems, genomics platforms, laboratory automation, centrifuges, particle analysis equipment, microscopes, and consumables for genomics, alongside Gene and Cell Therapy offerings. It further provides advanced bioprocess technologies, associated consumables, and support services. This segment is also a key supplier of filtration, separation, and purification technologies. Its clientele spans pharmaceutical and biopharmaceutical firms, food and beverage producers, medical organizations, life sciences enterprises, academic institutions including universities and medical schools, research facilities, and diverse industrial manufacturers. The Diagnostics segment specializes in diagnostic solutions, encompassing chemistry, immunoassay, microbiology, and automation systems, in addition to products for hematology, molecular diagnostics, acute care, and pathology. This segment supplies clinical instruments, reagents, consumables, software platforms, and related services to healthcare providers such as hospitals, doctors' offices, reference laboratories, and other vital critical care environments. The Environmental & Applied Solutions division provides a comprehensive suite of instrumentation, consumables, software, services, and disinfection systems. These offerings are crucial for the analysis, treatment, and management of various water types—including ultra-pure, drinking, industrial, waste, groundwater, source water, and ocean water—across residential, commercial, industrial, and natural resource contexts. Furthermore, this segment delivers instruments, software, services, and consumables supporting color and appearance management, packaging design and quality control, packaging conversion, printing, marking, coding, and traceability for consumer, pharmaceutical, and industrial goods. Established in 1969, the company initially operated as Diversified Mortgage Investors, Inc. before adopting the name Danaher Corporation in 1984. Its corporate headquarters are situated in Washington, D.C.
- CEO
- Julie Sawyer Montgomery
- Mitarbeitende
- 60.000
- Hauptsitz
- Washington, DC, US
- Sektor
- Healthcare
- Branche
- Medical - Diagnostics & Research
- Börsengang
- 15. Dez. 2003
- Website
- danaher.com
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.